For HIV-1–negative, at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1. See full Indication.

Resources

Access the resources below for additional details about APRETUDE, such as, the full Prescribing Information, including Instructions for Use, and downloadable resources such as dosing and drug interactions, getting started guide, and more.

Resources for Healthcare Professionals

PI

Prescribing Information

See the full Prescribing Information, including Boxed Warning, for APRETUDE

checkmark

Readiness Considerations Checklist

Review clinical considerations for appropriate patients when prescribing APRETUDE and readying your practice

checkmark

Getting Started Overview

Get detailed information on getting started with prescribed APRETUDE

CBTWCNT210025